DITE, Petr, Martin BLAHO, Martina BOJKOVA, Petr JABANDŽIEV and Lumír KUNOVSKÝ. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. Digestive Diseases. BASEL: KARGER, 2020, vol. 38, No 2, p. 143-149. ISSN 0257-2753. Available from: https://dx.doi.org/10.1159/000505366.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Nonalcoholic Fatty Pancreas Disease: Clinical Consequences
Authors DITE, Petr (203 Czech Republic), Martin BLAHO (203 Czech Republic), Martina BOJKOVA (203 Czech Republic), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution) and Lumír KUNOVSKÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Digestive Diseases, BASEL, KARGER, 2020, 0257-2753.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30219 Gastroenterology and hepatology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.404
RIV identification code RIV/00216224:14110/20:00115602
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000505366
UT WoS 000522852200011
Keywords in English Pancreas steatosis; Nonalcoholic fatty pancreas disease; Nonalcoholic steatopancreatitis; Metabolic syndrome; Cardiovascular diseases; Diabetes mellitus; Obesity; Pancreatic carcinoma; Exocrine pancreatic insufficiency
Tags 14110213, 14110223, 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 7/5/2020 09:02.
Abstract
Metabolic syndrome and its components such as obesity, hypertriglyceridemia, type-2 diabetes mellitus (DM-T2), and arterial hypertension are unequivocally serious problems for every society. This is especially true in economically developed countries where the imbalance in lifestyle between caloric intake and caloric output still gets greater and greater. This fact is not only a concern for the adult population but for children as well. However, metabolic syndrome does not only affect society and health in regards to cardiovascular diseases, it significantly concerns gastroenterology where it is classified as nonalcoholic fatty pancreas disease (NAFPD). The data gained from several trials show that the prevalence of NAFDP is 33% (95% CI 24-41%). When it comes to the diagnostic procedures concerning the presence of pancreatic fat, a whole spectrum of suitable methods are recommended. Probably, the most exact method is the use of magnetic resonance imaging. However, for common clinical practice, the abdominal sonographic examination based on the comparison of the pancreatic parenchymatous echogenity versus renal or hepatic echogenity is used. The clinical consequences of pancreatic steatosis and steatopancreatitis are significant. These diseases are connected with DM-T2 and insulin resistance. In recent years, changes of exocrine pancreatic function, particularly its decrease, have also been described. It is known that there is a close correlation between NAFPD and nonalcoholic hepatic steatosis and also with the increased thickness of aortic intima-media. There is also an important relationship between NAFPD and pancreatic carcinoma. Pancreatic steatosis, and especially its NAFPD form, is a serious state which can be treatable by the possible effective management of metabolic syndrome parameters, including obesity.
PrintDisplayed: 25/4/2024 05:50